Some patients may see slower progress over time
Whether reducing side effects like nausea, improving nerve health, or supporting cellular energy, these ingredients are carefully selected to create a better, more sustainable experience for the patient
Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment
Iacobellis G, Malavazos AE
What drugmakers are arguing about now is what kind of weight comes off, whether patients are losing fat or muscle, and what other benefits could be gained from these drugs
It is ideal for a quick check-in if you are already on a stable dose of medication